Tag: Prescription Drugs
Lenvatinib + Pembrolizumab Treats Advanced Endometrial Cancer
Progression-free, overall survival prolonged with lenvatinib plus pembrolizumab versus treating physician's choice of chemotherapy
Long-Acting Cabotegravir Not Necessarily Cost-Effective for PrEP
Benefits do not necessarily justify large price difference compared with generic F/TDF for men who have sex with men and transgender women
CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis
Incidences of major adverse cardiovascular events, cancers higher with tofacitinib versus TNF inhibitor; criteria for noninferiority not met
Remdesivir May Benefit Adults Early in COVID-19 Course
Real-world data support the use of remdesivir for hospitalized COVID-19 patients receiving no oxygen or low-flow oxygen
Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19
For asymptomatic SARS-CoV-2-positive individuals living with infected household contact, combo cuts incidence of symptomatic COVID-19
Psychotropic Medication Use Linked to Mortality in Cardiac Patients
Patients with symptoms of anxiety significantly more likely to use psychotropic medications after hospital discharge
Skyrizi Approved for Psoriatic Arthritis
Approval based on two Phase 3 trials showing more than 50 percent of patients receiving Skyrizi achieved ACR20 response at 24 weeks
FDA May Limit Use of Two COVID-19 Antibody Treatments
Treatments made by Regeneron and Eli Lilly performed well against earlier variants, but not against omicron
Opioid Overdose Antidote Urged for Schools After Student’s Fentanyl Death
In response to the incident, Hartford officials pledged to ensure that all city schools are stocked with naloxone
Microbiome Therapeutic Beats Placebo for Recurrent C. difficile
Investigational oral live microbiome therapeutic superior to placebo in patients with three or more episodes of C. difficile infection